Global leukocyte DNA methylation is not altered in euthymic bipolar patients

Journal of Affective Disorders

Volumn 118, Issue 1-3, 2009, Pages 234-239

  Bromberg, A ^a   Bersudsky, Y ^a   Levine, J ^a   Agam, G ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Bipolar disorder; Global DNA methylation; Leukocytes

Indexed keywords

DNA; HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BIPOLAR DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; DNA METHYLATION; DNA POLYMORPHISM; ENVIRONMENTAL FACTOR; EPIGENETICS; FEMALE; GENE MUTATION; GENETIC SUSCEPTIBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LEUKOCYTE; MALE; PRIORITY JOURNAL; PROMOTER REGION;

ADULT; BIPOLAR DISORDER; DNA METHYLATION; EPIGENESIS, GENETIC; FEMALE; HOMOCYSTEINE; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; REFERENCE VALUES; RISK FACTORS;

EID: 69949114948     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2009.01.031     Document Type: Article

References (52)

1. Abdolmaleky H.M., Cheng K.H., Faraone S.V., Wilcox M., Glatt S.J., Gao F., Smith C.L., Shafa R., Aeali B., Carnevale J., Pan H., Papageorgis P., Ponte J.F., Sivaraman V., Tsuang M.T., and Thiagalingam S. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder. Hum. Mol. Genet. 15 (2006) 3132-3145
2. Applebaum J., Shimon H., Sela B.A., Belmaker R.H., and Levine J. Homocysteine levels in newly admitted schizophrenic patients. J. Psychiatr. Res. 38 (2004) 413-416
3. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J. Chromatogr. 422 (1987) 43-52
4. Bonsch D., Lenz B., Reulbach U., Kornhuber J., and Bleich S. Homocysteine associated genomic DNA hypermethylation in patients with chronic alcoholism. J. Neural Transm. 111 (2004) 1611-1616
5. Bromberg A., Levine J., Nemetz B., Belmaker R.H., and Agam G. No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients. Schizophr. Res. 101 (2008) 50-57
6. Candelaria M., Gallardo-Rincon D., Arce C., Cetina L., Aguilar-Ponce J.L., Arrieta O., Gonzalez-Fierro A., Chavez-Blanco A., de la Cruz-Hernandez E., Camargo M.F., Trejo-Becerril C., Perez-Cardenas E., Perez-Plasencia C., Taja-Chayeb L., Wegman-Ostrosky T., Revilla-Vazquez A., and Duenas-Gonzalez A. A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors. Ann. Oncol. 18 (2007) 1529-1538
7. Castro R., Rivera I., Struys E.A., Jansen E.E., Ravasco P., Camilo M.E., Blom H.J., Jakobs C., and Tavares de Almeida I. Increased homocysteine and S-adenosylhomocysteine concentrations and DNA hypomethylation in vascular disease. Clin. Chem. 49 (2003) 1292-1296
8. Chen P.S., Wang C.C., Bortner C.D., Peng G.S., Wu X., Pang H., Lu R.B., Gean P.W., Chuang D.M., and Hong J.S. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity. Neuroscience 149 (2007) 203-212
9. Choi S.W., Friso S., Dolnikowski G.G., Bagley P.J., Edmondson A.N., Smith D.E., and Mason J.B. Biochemical and molecular aberrations in the rat colon due to folate depletion are age-specific. J. Nutr. 133 (2003) 1206-1212
10. Comb M., and Goodman H.M. CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2. Nucleic Acids Res. 18 (1990) 3975-3982
11. Costa E., Chen Y., Davis J., Dong E., Noh J.S., Tremolizzo L., Veldic M., Grayson D.R., and Guidotti A. REELIN and schizophrenia: a disease at the interface of the genome and the epigenome. Mol. Interv. 2 (2002) 47-57
12. Costa E., Dong E., Grayson D.R., Guidotti A., Ruzicka W., and Veldic M. Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability. Epigenetics 2 (2007) 29-36
13. Dittmann S., Seemuller F., Schwarz M.J., Kleindienst N., Stampfer R., Zach J., Born C., Bernhard B., Fast K., Grunze H., Engel R.R., and Severus E. Association of cognitive deficits with elevated homocysteine levels in euthymic bipolar patients and its impact on psychosocial functioning: preliminary results. Bipolar Disord. 9 (2007) 63-70
14. Dong E., Nelson M., Grayson D.R., Costa E., and Guidotti A. Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 113614-113619
15. Elashoff M., Higgs B.W., Yolken R.H., Knable M.B., Weis S., Webster M.J., Barci B.M., and Torrey E.F. Meta-analysis of 12 genomic studies in bipolar disorder. J. Mol. Neurosci. 31 (2007) 221-243
16. Feinberg A.P. Phenotypic plasticity and the epigenetics of human disease. Nature 447 (2007) 433-440
17. Friso S., and Choi S.W. Gene-nutrient interactions and DNA methylation. J. Nutr. 132 (2002) 2382S-2387S
18. Fuks F., Burgers W.A., Brehm A., Hughes-Davies L., and Kouzarides T. DNA methyltransferase Dnmt1 associates with histone deacetylase activity. Nat. Genet. 24 (2000) 88-91
19. Fuks F., Hurd P.J., Wolf D., Nan X., Bird A.P., and Kouzarides T. The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem. 278 (2003) 4035-4040
20. Fux R., Kloor D., Hermes M., Rock T., Proksch B., Grenz A., Delabar U., Bucheler R., Igel S., Morike K., Gleiter C.H., and Osswald H. Effect of acute hyperhomocysteinemia on methylation potential of erythrocytes and on DNA methylation of lymphocytes in healthy male volunteers. Am. J. Physiol., Renal. Physiol. 289 (2005) F786-792
21. Garcia-Manero G., Kantarjian H.M., Sanchez-Gonzalez B., Yang H., Rosner G., Verstovsek S., Rytting M., Wierda W.G., Ravandi F., Koller C., Xiao L., Faderl S., Estrov Z., Cortes J., O'Brien S., Estey E., Bueso-Ramos C., Fiorentino J., Jabbour E., and Issa J.P. Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemia. Blood 108 (2006) 3271-3279
22. Grayson D.R., Jia X., Chen Y., Sharma R.P., Mitchell C.P., Guidotti A., and Costa E. Reelin promoter hypermethylation in schizophrenia. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 9341-9346
23. Guidotti A., Ruzicka W., Grayson D.R., Veldic M., Pinna G., Davis J.M., and Costa E. S-adenosyl methionine and DNA methyltransferase-1 mRNA overexpression in psychosis. Neuroreport 18 (2007) 57-60
24. Herman J.G., and Baylin S.B. Gene silencing in cancer in association with promoter hypermethylation. N. Engl. J. Med. 349 (2003) 2042-2054
25. Iwamoto K., Bundo M., Yamada K., Takao H., Iwayama-Shigeno Y., Yoshikawa T., and Kato T. DNA methylation status of SOX10 correlates with its downregulation and oligodendrocyte dysfunction in schizophrenia. J. Neurosci. 25 (2005) 5376-5381
26. Jones P.A., and Takai D. The role of DNA methylation in mammalian epigenetics. Science 293 (2001) 1068-1070
27. Karimi M., Johansson S., Stach D., Corcoran M., Grander D., Schalling M., Bakalkin G., Lyko F., Larsson C., and Ekstrom T.J. LUMA (LUminometric Methylation Assay)-a high throughput method to the analysis of genomic DNA methylation. Exp. Cell Res. 312 (2006) 1989-1995
28. Kato T., Iwamoto K., Kakiuchi C., Kuratomi G., and Okazaki Y. Genetic or epigenetic difference causing discordance between monozygotic twins as a clue to molecular basis of mental disorders. Mol. Psychiatry 10 (2005) 622-630
29. Kuratomi G., Iwamoto K., Bundo M., Kusumi I., Kato N., Iwata N., Ozaki N., and Kato T. Aberrant DNA methylation associated with bipolar disorder identified from discordant monozygotic twins. Mol. Psychiatry 13 (2007) 429-441
30. Levine J., Sela B.A., Osher Y., and Belmaker R.H. High homocysteine serum levels in young male schizophrenia and bipolar patients and in an animal model. Prog. Neuro-psychopharmacol. Biol. Psychiatry 29 (2005) 1181-1191
31. Lin R.K., Hsu H.S., Chang J.W., Chen C.Y., Chen J.T., and Wang Y.C. Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. Lung Cancer 55 (2007) 205-213
32. Meaney M.J., and Szyf M. Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome. Dialogues Clin. Neurosci. 7 (2005) 103-123
33. Mill J., and Petronis A. Molecular studies of major depressive disorder: the epigenetic perspective. Mol. Psychiatry 12 (2007) 799-814
34. Mill J., Tang T., Kaminsky Z., Khare T., Yazdanpanah S., Bouchard L., Jia P., Assadzadeh A., Flanagan J., Schumacher A., Wang S.C., and Petronis A. Epigenomic profiling reveals DNA-methylation changes associated with major psychosis. Am. J. Hum. Genet. 82 (2008) 696-711
35. Nan X., Ng H.H., Johnson C.A., Laherty C.D., Turner B.M., Eisenman R.N., and Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 393 (1998) 386-389
36. Nevo G.A., Meged S., Sela B.A., Hanoch-Levi A., Hershko R., and Weizman A. Homocysteine levels in adolescent schizophrenia patients. Eur. Neuropsychopharmacol. 16 (2006) 588-591
37. Oh G., and Petronis A. Environmental studies of schizophrenia through the prism of epigenetics. Schizophr. Bull. 34 (2008) 1122-1129
38. Osher Y., Sela B.A., Levine J., and Belmaker R.H. Elevated homocysteine levels in euthymic bipolar disorder patients showing functional deterioration. Bipolar Disord. 6 (2004) 82-86
39. Osher Y., Bersudsky Y., Silver H., Sela B.A., and Belmaker R.H. Neuropsychological correlates of homocysteine levels in euthymic bipolar patients. J. Affect. Disord. 105 (2008) 229-233
40. Pogribny I., Yi P., and James S.J. A sensitive new method for rapid detection of abnormal methylation patterns in global DNA and within CpG islands. Biochem. Biophys. Res. Commun. 262 (1999) 624-628
41. Robertson K.D., and Wolffe A.P. DNA methylation in health and disease. Nat. Rev., Genet. 1 (2000) 11-19
42. Rosa A., Picchioni M.M., Kalidindi S., Loat C.S., Knight J., Toulopoulou T., Vonk R., van der Schot A.C., Nolen W., Kahn R.S., McGuffin P., Murray R.M., and Craig I.W. Differential methylation of the X-chromosome is a possible source of discordance for bipolar disorder female monozygotic twins. Am. J. Med. Genet. B., Neuropsychiatr. Genet. 147B (2008) 459-462
43. Schneede J., Refsum H., and Ueland P.M. Biological and environmental determinants of plasma homocysteine. Semin. Thromb. Hemost. 26 (2000) 263-279
44. Sharma R.P., Rosen C., Kartan S., Guidotti A., Costa E., Grayson D.R., and Chase K. Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population. Schizophr. Res. 88 (2006) 227-231
45. Singh S.M., Murphy B., and O'Reilly R.L. Involvement of gene-diet/drug interaction in DNA methylation and its contribution to complex diseases: from cancer to schizophrenia. Clin. Genet. 64 (2003) 451-460
46. Smith I.M., Mydlarz W.K., Mithani S.K., and Califano J.A. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int. J. Cancer 121 (2007) 1724-1728
47. Stahl Z., Belmaker R.H., Friger M., and Levine J. Nutritional and life style determinants of plasma homocysteine in schizophrenia patients. Eur. Neuropsychopharmacol. 15 (2005) 291-295
48. Stenvinkel P., Karimi M., Johansson S., Axelsson J., Suliman M., Lindholm B., Heimburger O., Barany P., Alvestrand A., Nordfors L., Qureshi A.R., Ekstrom T.J., and Schalling M. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?. J. Intern. Med. 261 (2007) 488-499
49. Tamura Y., Kunugi H., Ohashi J., and Hohjoh H. Epigenetic aberration of the human REELIN gene in psychiatric disorders. Mol. Psychiatry 12 519 (2007) 593-600
50. van Vliet J., Oates N.A., and Whitelaw E. Epigenetic mechanisms in the context of complex diseases. Cell. Mol. Life Sci. 64 (2007) 1531-1538
51. Veldic M., Guidotti A., Maloku E., Davis J.M., and Costa E. In psychosis, cortical interneurons overexpress DNA-methyltransferase 1. Proc. Natl. Acad. Sci. U. S. A. 102 (2005) 2152-2157
52. Yi P., Melnyk S., Pogribna M., Pogribny I.P., Hine R.J., and James S.J. Increase in plasma homocysteine associated with parallel increases in plasma S-adenosylhomocysteine and lymphocyte DNA hypomethylation. J. Biol. Chem. 275 (2000) 29318-29323